Oak Hill Bio

Tellus Therapeutics

This company develops biopharmaceutical treatments for white matter brain injury in premature infants to improve neurodevelopmental outcomes.

Mahzi Therapeutics

This biotechnology company develops gene and antisense oligonucleotide therapies for patients with rare genetic neurodevelopmental disorders.

Nilo Therapeuti

This biotechnology company develops medicines that target neural circuits to treat patients with autoimmune and inflammatory diseases.

Mereo BioPharma

The company develops clinical-stage therapies for patients with rare diseases, including osteogenesis imperfecta and alpha-1 antitrypsin deficiency-associated lung disease.

Hillstar Bio

This biotechnology company develops precision immunology therapies that target and deplete pathogenic immune cells for patients with autoimmune diseases.

BlossomHill Therapeutics

This biopharmaceutical company develops small molecule medicines to treat patients with various forms of cancer and autoimmune disorders.

HI-Bio

This biotechnology company develops targeted therapies for patients suffering from severe immune-mediated diseases.

Ethyreal Bio

This company develops monoclonal antibodies to treat Graves' disease and thyroid eye disease for patients with these autoimmune conditions.